CLL/SLL/Hairy Cell Leukemia Panel - Disclosures
Panel Member
|
Jeremy Abramson MD, MMSc |
Grant/Research Support
|
| Bristol Myers Squibb | Celgene Corporation | Genentech, Inc. | Merck & Co., Inc. | Mustang Bio | Regeneron Pharmactcls | SeaGen | Takeda Pharmaceuticals North America, Inc. |
Date Completed
|
07/29/2024 |
Panel Member
|
Farrukh Awan MD |
Grant/Research Support
|
| AbbVie, Inc. | Pharmacyclics |
Date Completed
|
06/30/2024 |
Panel Member
|
Syed Bilgrami MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Greg Bociek MD, MSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Daniel Boyer MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jennifer Brown MD, PhD |
Grant/Research Support
|
| BeiGene | Eli Lilly and Company | Gilead Sciences, Inc. | iOnctura | MEI Pharma Inc. | Nagoon Therapeutics | TG Therapeutics |
Date Completed
|
05/12/2025 |
Panel Member
|
Matthew Cortese MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Larry Cripe MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Randall Davis MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Zeenat Diwan PhD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mary Dwyer MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Herbert Eradat MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lindsey Fitzgerald MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christopher Fletcher MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sameh Gaballa MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Muhammad Saad Hamid MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brian Hill MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Megan Hollasch |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Madeline Joyce BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Paul Kaesberg MD |
Product/Speakers Bureau
|
| BeiGene | Janssen Pharmaceutica Products, LP |
Date Completed
|
05/14/2024 |
Panel Member
|
Brad Kahl MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Manali Kamdar MD |
Grant/Research Support
|
| Novartis Pharmaceuticals Corporation |
Date Completed
|
03/18/2025 |
Panel Member
|
Ann Karosas RPh, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Thomas Kipps MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Shuo Ma MD, PhD |
Grant/Research Support
|
| AbbVie, Inc. | AstraZeneca Pharmaceuticals LP | BeiGene | Carna | Eli Lilly and Company | Janssen Pharmaceutica Products, LP | Juno Therapeutics, Inc. |
Product/Speakers Bureau
|
| AstraZeneca Pharmaceuticals LP | BeiGene | Eli Lilly and Company |
Date Completed
|
06/27/2024 |
Panel Member
|
Kristen Morris BSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Claudio Mosse MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Shazia Nakhoda MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sameer Parikh MBBS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Peter Riedell MD |
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Calibr | CARGO Therapeutics | Cellectis | CRISPR Therapeutics | Fate Therapeutics | Genentech, Inc. | Kite Pharma | Tessa Therapeutics | Xencor |
Date Completed
|
01/20/2025 |
Panel Member
|
Tim Rinehart |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Andrew Schorr MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Stephen Schuster MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Madhav Seshadri MD |
Grant/Research Support
|
| Cabaletta Bio | Eli Lilly and Company | Genentech, Inc. | Kyverna Therapeutics |
Date Completed
|
05/05/2025 |
Panel Member
|
Tait Shanafelt MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tanya Siddiqi MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Andrea Sitlinger MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Hema Sundar PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Meghan Thompson MD |
Grant/Research Support
|
| AbbVie, Inc. | Adaptive Biotechnologies | AstraZeneca Pharmaceuticals LP | BeiGene | Genentech, Inc. | Genmab | Nurix Therapeutics |
Date Completed
|
03/30/2025 |
Panel Member
|
Chaitra Ujjani MD |
Grant/Research Support
|
| AbbVie, Inc. | AstraZeneca Pharmaceuticals LP | Eli Lilly and Company | Kite Pharma | Pharmacyclics |
Date Completed
|
03/19/2025 |
Panel Member
|
Nina Wagner-Johnston MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
William Wierda MD, PhD |
Grant/Research Support
|
| AbbVie, Inc. | Acerta Pharma | BeiGene | Bristol Myers Squibb | Cyclacel Pharmaceutixals | Genentech, Inc. | Gilead Sciences, Inc. | GlaxoSmithKline | Janssen Biotech | Juno Therapeutics, Inc. | Kite Pharma | LOXO Oncology | Novartis Pharmaceuticals Corporation | Numab Therapeutics | Nurix | Oncternal Therapeutics | Pharmacyclics |
Date Completed
|
01/16/2025 |
Panel Member
|
Jennifer Woyach MD |
Grant/Research Support
|
| AbbVie, Inc. | BeiGene | Eli Lilly and Company | Johnson & Johnson | Merck & Co., Inc. | Pharmacyclics | Schrodinger Ing REG SHS |
Date Completed
|
01/06/2025 |